EP Patent

EP2322168A1 — Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments

Assigned to Parkinsons Institute · Expires 2011-05-18 · 15y expired

What this patent protects

The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dop…

USPTO Abstract

The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.

Drugs covered by this patent

Patent Metadata

Patent number
EP2322168A1
Jurisdiction
EP
Classification
—
Expires
2011-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Parkinsons Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.